The evidence supports that this multi-strain synbiotic has been studied in randomized, placebo-controlled trials and can improve certain microbiome-related measures. In healthy adults, it increased some beneficial bacteria and metabolites such as butyrate, and in another trial it was associated with improved gut barrier integrity during and after antibiotics. The evidence provided supports microbiome and digestive-function outcomes more than broad whole-body health claims.

Seed is a company focused on microbial sciences, aiming to enhance human and planetary health through innovative applications of microbes. Their flagship product, the DS-01® Daily Synbiotic, is designed to support gut health by combining probiotics and prebiotics. This synbiotic formulation is intended to improve digestive health, support the immune system, and promote overall well-being.

The DS-01® Daily Synbiotic is based on scientific research and is developed to ensure the delivery of beneficial bacteria to the gut. This product is part of Seed's broader commitment to advancing the understanding and application of microbiome science. By focusing on the gut microbiome, Seed aims to provide a foundation for improved health outcomes through the modulation of microbial communities within the body.